Dihydrolipoamide dehydrogenase (E3) is a common flavoprotein component of the alpha-keto acid dehydrogenase complexes involved in the oxidation of pyruvate, alpha-ketoglutarate and branched-chain alpha-keto acids in the mitochondria. E3-deficient patients show developmental delay and severe neurologic disabilities. The long term goal of this proposal is to continue to enhance our understanding of the structure-function relationship of human E3 at the level of protein and transcriptional regulation of the gene in normal and disease states. Based on our recent findings we have expanded the scope of this proposal.
Five specific aims of this proposal are: (i) to investigate the structure-function relationship of normal and site-specifically mutated human E3s by measuring kinetic and spectral characteristics, (ii) to determine the crystal structure of normal and mutant human E3s, (iii) to characterize the transcriptional regulation of the promoter region of the human E3 gene by hormones in cultured cells and developmental and tissue-specific regulation in transgenic mice, (iv) to characterize the molecular basis for E3 deficiency in affected patients, and (v) to regulate the expression of human E3 in cells to investigate possible metabolic consequences. We have constructed a prokaryotic expression vector which is capable of producing large quantities of recombinant human E3 required for structural studies. Initial characterization of the human E3 promoter indicates that this promoter has several unique characteristics for a """"""""housekeeping"""""""" gene and is subject to hormonal manipulations. Mutation analysis in E3- deficient patients has already enhanced our understanding of the structure-function relationship and is likely to contribute significantly to the proposed studies. Our multifaceted collaborative approach to studying human E3 at the protein and gene levels should further contribute to our knowledge of the structure-function relationship of E3 protein and transcriptional regulation of the E3 gene.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK042885-04A1
Application #
2142614
Study Section
Medical Biochemistry Study Section (MEDB)
Project Start
1990-08-01
Project End
1998-06-30
Budget Start
1994-07-15
Budget End
1995-06-30
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
State University of New York at Buffalo
Department
Biochemistry
Type
Schools of Dentistry
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Halim, Nader D; Mcfate, Thomas; Mohyeldin, Ahmed et al. (2010) Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons. Glia 58:1168-76
Ciszak, Ewa M; Makal, Anna; Hong, Young S et al. (2006) How dihydrolipoamide dehydrogenase-binding protein binds dihydrolipoamide dehydrogenase in the human pyruvate dehydrogenase complex. J Biol Chem 281:648-55
Korotchkina, Lioubov G; Sidhu, Sukhdeep; Patel, Mulchand S (2004) R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase. Free Radic Res 38:1083-92
Johnson, Mark T; Mahmood, Saleh; Patel, Mulchand S (2003) Intermediary metabolism and energetics during murine early embryogenesis. J Biol Chem 278:31457-60
Hong, Y S; Korman, S H; Lee, J et al. (2003) Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: possible beneficial effect of vitamin therapy. J Inherit Metab Dis 26:816-8
Patel, Mulchand S; Korotchkina, Lioubov G (2002) Pyruvate dehydrogenase complex as a marker of mitochondrial metabolism. Inhibition by 4-hydroxy-2-nonenal. Methods Mol Biol 186:255-63
Yang, H S; Morris, J I; Wang, Q et al. (2001) Human dihydrolipoamide dehydrogenase gene transcription is mediated by cAMP-response element-like site and TACGAC direct repeat. Int J Biochem Cell Biol 33:902-13
Korotchkina, L G; Yang, H; Tirosh, O et al. (2001) Protection by thiols of the mitochondrial complexes from 4-hydroxy-2-nonenal. Free Radic Biol Med 30:992-9
Patel, M S; Hong, Y S; Kerr, D S (2000) Genetic defects in E3 component of alpha-keto acid dehydrogenase complexes. Methods Enzymol 324:453-64
Johnson, M T; Yang, H S; Patel, M S (2000) Targeting E3 component of alpha-keto acid dehydrogenase complexes. Methods Enzymol 324:465-76

Showing the most recent 10 out of 30 publications